Top Header Band
Covishield banner
CGMP Manufacturing Facility

GMP
Manufacturing
Facility

Serum Life Sciences will leverage Serum Institute of India's capabilities of manufacturing vaccines and will construct a 1 billion dose SARS-CoV-2 multi-product bulk and full finish facility to manufacture multiple Covid-19 vaccines in India.

News